Key statistics
On Tuesday, Edgewise Therapeutics Inc (EWTX:NSQ) closed at 35.20, -7.66% below its 52-week high of 38.12, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.24 |
---|---|
High | 35.99 |
Low | 34.00 |
Bid | 34.95 |
Offer | 35.15 |
Previous close | 35.33 |
Average volume | 770.34k |
---|---|
Shares outstanding | 93.77m |
Free float | 93.33m |
P/E (TTM) | -- |
Market cap | 3.31bn USD |
EPS (TTM) | -1.49 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
- Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
- Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
- Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time